SCALE Healthcare Leadership Conference on October 18, 2023 at 8:00 AM-6:00 PM. Click here to register

Limited Uptake of Biosimilars Despite Potential Cost Savings

Biosimilar Cost Savings

Limited Uptake of Biosimilars Despite Potential Cost Savings: Patent Expiration and Value-Based Contracting to Drive Market Changes  Summary: Biosimilars are drugs that reference a biologic and are concentrated in high-cost specialty drug markets such as oncology.  Despite potential for cost savings in Medicare and other markets, uptake of biosimilars in the US has historically been […]

Log in

If you are a community member

Thanks for visiting!

Put your email and we promise we won’t spam you. We have so much to show you.

Join SCALE Community

We are excited for you to share in the benefits of SCALE community’s healthcare focus materials. If you are not currently a member sign up now to get unlimited access to all our materials.